| Profile | GDS5420 / 212484_at |
| Title | Psoriasis response to brodalumab: dose response and time course |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM1296094 | A_lesional_pre-dose | 496.61 | 67 |
| GSM1296119 | B_lesional_pre-dose | 170.92 | 49 |
| GSM1296076 | C_lesional_pre-dose | 255.86 | 58 |
| GSM1296092 | D_lesional_pre-dose | 707.08 | 73 |
| GSM1296103 | E_lesional_pre-dose | 568.21 | 70 |
| GSM1296078 | F_lesional_pre-dose | 271.31 | 59 |
| GSM1296107 | G_lesional_pre-dose | 196 | 51 |
| GSM1296109 | H_lesional_pre-dose | 303.06 | 58 |
| GSM1296080 | I_lesional_pre-dose | 731.16 | 74 |
| GSM1296090 | J_lesional_pre-dose | 603.33 | 71 |
| GSM1296074 | K_lesional_pre-dose | 352.12 | 63 |
| GSM1296111 | L_lesional_pre-dose | 181.27 | 50 |
| GSM1296099 | M_lesional_pre-dose | 324.36 | 60 |
| GSM1296086 | O_lesional_pre-dose | 590.87 | 71 |
| GSM1296117 | P_lesional_pre-dose | 223.67 | 53 |
| GSM1296113 | Q_lesional_pre-dose | 204 | 51 |
| GSM1296096 | R_lesional_pre-dose | 331.74 | 61 |
| GSM1296105 | S_lesional_pre-dose | 467.43 | 66 |
| GSM1296098 | T_lesional_pre-dose | 358.94 | 62 |
| GSM1296101 | U_lesional_pre-dose | 494.38 | 67 |
| GSM1296121 | V_lesional_pre-dose | 166.42 | 49 |
| GSM1296088 | W_lesional_pre-dose | 667.24 | 72 |
| GSM1296082 | X_lesional_pre-dose | 545.82 | 70 |
| GSM1296115 | Y_lesional_pre-dose | 186.9 | 51 |
| GSM1296084 | Z_lesional_pre-dose | 598.41 | 71 |
| GSM1296072 | B_lesional_day8 | 288.65 | 58 |
| GSM1296069 | L_lesional_day8 | 165.76 | 47 |
| GSM1296071 | P_lesional_day8 | 277.41 | 56 |
| GSM1296070 | Y_lesional_day8 | 192.94 | 50 |
| GSM1296073 | V_lesional_day8 | 180.51 | 51 |
| GSM1296034 | A_lesional_day15 | 471.52 | 66 |
| GSM1296041 | G_lesional_day15 | 208.49 | 53 |
| GSM1296035 | R_lesional_day15 | 402.97 | 64 |
| GSM1296038 | U_lesional_day15 | 494.73 | 68 |
| GSM1296047 | B_lesional_day15 | 270.31 | 56 |
| GSM1296039 | E_lesional_day15 | 225.42 | 55 |
| GSM1296042 | H_lesional_day15 | 269.34 | 56 |
| GSM1296043 | L_lesional_day15 | 259.73 | 55 |
| GSM1296037 | M_lesional_day15 | 390.44 | 63 |
| GSM1296046 | P_lesional_day15 | 243.58 | 54 |
| GSM1296044 | Q_lesional_day15 | 265.73 | 56 |
| GSM1296045 | Y_lesional_day15 | 209.93 | 51 |
| GSM1296025 | C_lesional_day15 | 285.69 | 59 |
| GSM1296033 | D_lesional_day15 | 735.22 | 74 |
| GSM1296027 | I_lesional_day15 | 714.14 | 74 |
| GSM1296032 | J_lesional_day15 | 663.39 | 72 |
| GSM1296024 | K_lesional_day15 | 350.8 | 62 |
| GSM1296031 | W_lesional_day15 | 673.62 | 72 |
| GSM1296028 | X_lesional_day15 | 647.78 | 72 |
| GSM1296029 | Z_lesional_day15 | 781.98 | 75 |
| GSM1296026 | F_lesional_day15 | 387.21 | 64 |
| GSM1296030 | O_lesional_day15 | 869.88 | 77 |
| GSM1296040 | S_lesional_day15 | 413.45 | 64 |
| GSM1296036 | T_lesional_day15 | 475.92 | 66 |
| GSM1296048 | V_lesional_day15 | 190.96 | 51 |
| GSM1296059 | A_lesional_day43 | 509.8 | 68 |
| GSM1296066 | G_lesional_day43 | 228.89 | 54 |
| GSM1296060 | R_lesional_day43 | 338.47 | 61 |
| GSM1296063 | U_lesional_day43 | 329.61 | 61 |
| GSM1296064 | E_lesional_day43 | 329.58 | 61 |
| GSM1296067 | H_lesional_day43 | 342.65 | 60 |
| GSM1296062 | M_lesional_day43 | 471.75 | 66 |
| GSM1296068 | Q_lesional_day43 | 220.49 | 52 |
| GSM1296050 | C_lesional_day43 | 282.81 | 58 |
| GSM1296057 | D_lesional_day43 | 400.75 | 64 |
| GSM1296052 | I_lesional_day43 | 672.86 | 73 |
| GSM1296054 | J_lesional_day43 | 784.8 | 75 |
| GSM1296049 | K_lesional_day43 | 366.56 | 63 |
| GSM1296055 | W_lesional_day43 | 350.36 | 61 |
| GSM1296053 | X_lesional_day43 | 669.94 | 72 |
| GSM1296058 | Z_lesional_day43 | 471.33 | 67 |
| GSM1296051 | F_lesional_day43 | 345.53 | 62 |
| GSM1296056 | O_lesional_day43 | 373.58 | 63 |
| GSM1296065 | S_lesional_day43 | 293.57 | 58 |
| GSM1296061 | T_lesional_day43 | 451.85 | 65 |
| GSM1296095 | A_non-lesional_pre-dose | 386.02 | 64 |
| GSM1296120 | B_non-lesional_pre-dose | 240.65 | 54 |
| GSM1296077 | C_non-lesional_pre-dose | 288.73 | 59 |
| GSM1296093 | D_non-lesional_pre-dose | 722.54 | 73 |
| GSM1296104 | E_non-lesional_pre-dose | 274.04 | 58 |
| GSM1296079 | F_non-lesional_pre-dose | 358.37 | 63 |
| GSM1296108 | G_non-lesional_pre-dose | 252.13 | 55 |
| GSM1296110 | H_non-lesional_pre-dose | 271.23 | 56 |
| GSM1296081 | I_non-lesional_pre-dose | 645.15 | 72 |
| GSM1296091 | J_non-lesional_pre-dose | 835.31 | 76 |
| GSM1296075 | K_non-lesional_pre-dose | 323.15 | 61 |
| GSM1296112 | L_non-lesional_pre-dose | 272.5 | 56 |
| GSM1296100 | M_non-lesional_pre-dose | 362.24 | 62 |
| GSM1296087 | O_non-lesional_pre-dose | 710.7 | 74 |
| GSM1296118 | P_non-lesional_pre-dose | 221.2 | 52 |
| GSM1296114 | Q_non-lesional_pre-dose | 200.4 | 51 |
| GSM1296097 | R_non-lesional_pre-dose | 284.84 | 58 |
| GSM1296106 | S_non-lesional_pre-dose | 339.09 | 60 |
| GSM1296102 | U_non-lesional_pre-dose | 407.96 | 63 |
| GSM1296122 | V_non-lesional_pre-dose | 183.64 | 50 |
| GSM1296089 | W_non-lesional_pre-dose | 791.33 | 75 |
| GSM1296083 | X_non-lesional_pre-dose | 585.55 | 70 |
| GSM1296116 | Y_non-lesional_pre-dose | 217.29 | 52 |
| GSM1296085 | Z_non-lesional_pre-dose | 596.79 | 70 |